Cover Image

Farnesoid-X receptor as a therapeutic target for inflammatory bowel disease and colorectal cancer

Farnesoid-X receptor (FXR), as a nuclear receptor activated by bile acids, is a vital molecule involved in bile acid metabolism. Due to its expression in immune cells, FXR has a significant effect on the function of immune cells and the release of chemokines when immune cells sense changes in bile a...

Full description

Saved in:

Bibliographic Details
Main Authors:	Mengjiao Zhou (Author), Danfeng Wang (Author), Xiang Li (Author), Ying Cao (Author), Chengxue Yi (Author), Dickson Kofi Wiredu Ocansey (Author), Yuling Zhou (Author), Fei Mao (Author)
Format:	Book
Published:	Frontiers Media S.A., 2022-10-01T00:00:00Z.
Subjects:	article
Online Access:	Connect to this object online.
Tags:	Add Tag No Tags, Be the first to tag this record!

Similar Items

Therapeutic Prospects of Mesenchymal Stem Cell and Their Derived Exosomes in the Regulation of the Gut Microbiota in Inflammatory Bowel Disease
by: Yaru Qiao, et al.
Published: (2024)

The Achievements and Challenges of Mesenchymal Stem Cell-Based Therapy in Inflammatory Bowel Disease and Its Associated Colorectal Cancer
by: Dickson Kofi Wiredu Ocansey, et al.
Published: (2020)

The Effects of Mesenchymal Stem Cell on Colorectal Cancer
by: Jintao Yuan, et al.
Published: (2021)

Regulatory Effect of Mesenchymal Stem Cells on T Cell Phenotypes in Autoimmune Diseases
by: Zhiping Wei, et al.
Published: (2021)

The Function of Necroptosis and Its Treatment Target in IBD
by: Francis Atim Akanyibah, et al.
Published: (2024)

hucMSC-Ex Alleviates IBD-Associated Intestinal Fibrosis by Inhibiting ERK Phosphorylation in Intestinal Fibroblasts
by: Yifei Wang, et al.
Published: (2023)

Natural Products Targeting Liver X Receptors or Farnesoid X Receptor
by: Jianglian She, et al.
Published: (2022)

Downregulation of the farnesoid X receptor promotes colorectal tumorigenesis by facilitating enterotoxigenic Bacteroides fragilis colonization
by: Suhang Guo, et al.
Published: (2022)

Irisin Is Controlled by Farnesoid X Receptor and Regulates Cholesterol Homeostasis
by: Hong Li, et al.
Published: (2019)

Farnesoid X Receptor Agonists as Therapeutic Target for Cardiometabolic Diseases
by: Chao Li, et al.
Published: (2020)

Farnesoid X receptor, the bile acid sensing nuclear receptor, in liver regeneration
by: Guodong Li, et al.
Published: (2015)

Role of farnesoid X receptor and bile acids in alcoholic liver disease
by: Sharon Manley, et al.
Published: (2015)

The Emerging Clinical Application of m6A RNA Modification in Inflammatory Bowel Disease and Its Associated Colorectal Cancer
by: Xu X, et al.
Published: (2021)

The Decrease in Farnesoid X Receptor, Pregnane X Receptor and Constitutive Androstane Receptor in the Liver after Intestinal Ischemia-Reperfusion
by: Jiro Ogura, et al.
Published: (2012)

The Novel Compounds That Activate Farnesoid X Receptor: the Diversity of Their Effects on Gene Expression
by: Takuo Suzuki, et al.
Published: (2008)

Potential of guggulsterone, a farnesoid X receptor antagonist, in the prevention and treatment of cancer
by: Sosmitha Girisa, et al.
Published: (2020)

A combined nanotherapeutic approach targeting farnesoid X receptor, ferroptosis, and fibrosis for nonalcoholic steatohepatitis treatment
by: Jiangtao Fu, et al.
Published: (2024)

Repositioning an Immunomodulatory Drug Vidofludimus as a Farnesoid X Receptor Modulator With Therapeutic Effects on NAFLD
by: Yanlin Zhu, et al.
Published: (2020)

Probucol ameliorates hepatic stellate cell activation and autophagy is associated with farnesoid X receptor
by: Ruhui Yang, et al.
Published: (2019)

Farnesoid X receptor ‐ a molecular predictor of weight loss after vertical sleeve gastrectomy?
by: F. Scott, et al.
Published: (2019)

Xanthohumol improves cognition in farnesoid X receptor-deficient mice on a high-fat diet
by: Payel Kundu, et al.
Published: (2022)

Ginsenoside Rc attenuates DSS-induced ulcerative colitis, intestinal inflammatory, and barrier function by activating the farnesoid X receptor
by: Kaijia Tang, et al.
Published: (2022)

Baicalin Protects Against 17α-Ethinylestradiol-Induced Cholestasis via the Sirtuin 1/Hepatic Nuclear Receptor-1α/Farnesoid X Receptor Pathway
by: Jinyu Yang, et al.
Published: (2020)

Human Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of ASC42, a Novel Farnesoid X Receptor Agonist
by: Handan He, et al.
Published: (2023)

Xanthohumol ameliorates Diet-Induced Liver Dysfunction via Farnesoid X Receptor-Dependent and Independent Signaling
by: Ines L. Paraiso, et al.
Published: (2021)

Farnesoid X receptor activation protects against renal fibrosis via modulation of β-catenin signaling
by: Dan-Qin Sun, et al.
Published: (2024)

Pharmacokinetics, pharmacodynamics, safety and tolerability of cilofexor, a novel nonsteroidal Farnesoid X receptor agonist, in healthy volunteers
by: Islam R. Younis, et al.
Published: (2023)

Assessment of drug-drug interaction potential with EDP‐305, a farnesoid X receptor agonist, in healthy subjects
by: Alaa Ahmad, et al.
Published: (2022)

Role of farnesoid X receptor in establishment of ontogeny of phase-I drug metabolizing enzyme genes in mouse liver
by: Lai Peng, et al.
Published: (2016)

Farnesoid X receptor agonist INT-767 attenuates liver steatosis and inflammation in rat model of nonalcoholic steatohepatitis
by: Hu YB, et al.
Published: (2018)

Calculus Bovis Sativus Improves Bile Acid Homeostasis via Farnesoid X Receptor-Mediated Signaling in Rats With Estrogen-Induced Cholestasis
by: Dong Xiang, et al.
Published: (2019)

Mucin-Type O-Glycans: Barrier, Microbiota, and Immune Anchors in Inflammatory Bowel Disease
by: Zhang Y, et al.
Published: (2021)

Farnesoid X Receptor Agonist as a new treatment option for Non-Alcoholic Fatty Liver disease: A Review
by: Sukhpreet Singh, et al.
Published: (2017)

EDP‐297: A novel, farnesoid X receptor agonist-Results of a phase I study in healthy subjects
by: Christine Marotta, et al.
Published: (2023)

New mechanistic insights into hepatoprotective activity of milk thistle and chicory quantified extract: The role of hepatic Farnesoid-X activated receptors
by: Azadeh Khalili, et al.
Published: (2021)

Saffron offers hepatoprotection via up-regulation of hepatic farnesoid-X-activated receptors in a rat model of acetaminophen-induced hepatotoxicity
by: Vahid Jamshidi, et al.
Published: (2021)

Role of Fasting Mimicking Diet in Farnesoid x Receptor for Suppressing Epithelial-to-Mesenchymal Transition, Cell Cycle Progression, and Viability of Prostate Cancer Cells
by: Wrood Salim, et al.
Published: (2023)

Paeoniflorin alleviates 17α-ethinylestradiol-induced cholestasis via the farnesoid X receptor-mediated bile acid homeostasis signaling pathway in rats
by: Rulin Wang, et al.
Published: (2022)

Bile duct ligation differently regulates protein expressions of organic cation transporters in intestine, liver and kidney of rats through activation of farnesoid X receptor by cholate and bilirubin
by: Shijin Hong, et al.
Published: (2023)

Farnesoid X receptor contributes to body weight-independent improvements in glycemic control after Roux-en-Y gastric bypass surgery in diet-induced obese mice
by: Kun Li, et al.
Published: (2020)